These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28751304)

  • 1. A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic
    Oldenburg A; Briand N; Sørensen AL; Cahyani I; Shah A; Moskaug JØ; Collas P
    J Cell Biol; 2017 Sep; 216(9):2731-2743. PubMed ID: 28751304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
    Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
    Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
    Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
    Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
    Friesen M; Cowan CA
    Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
    Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV
    Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipodystrophic laminopathy: Lamin A mutation relaxes chromatin architecture to impair adipogenesis.
    Elzeneini E; Wickström SA
    J Cell Biol; 2017 Sep; 216(9):2607-2610. PubMed ID: 28811278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
    Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamin A/C mutation associated with lipodystrophy influences adipogenic differentiation of stem cells through interaction with Notch signaling.
    Perepelina K; Dmitrieva R; Ignatieva E; Borodkina A; Kostareva A; Malashicheva A
    Biochem Cell Biol; 2018 Jun; 96(3):342-348. PubMed ID: 29040816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
    Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
    Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
    Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
    Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the myodystrophic R453W mutation of lamin A in C2C12 myoblasts causes promoter-specific and global epigenetic defects.
    Håkelien AM; Delbarre E; Gaustad KG; Buendia B; Collas P
    Exp Cell Res; 2008 May; 314(8):1869-80. PubMed ID: 18396274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminopathy-causing lamin A mutations reconfigure lamina-associated domains and local spatial chromatin conformation.
    Briand N; Collas P
    Nucleus; 2018 Jan; 9(1):216-226. PubMed ID: 29517398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
    Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
    J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
    Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C
    Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.
    Verstraeten VL; Caputo S; van Steensel MA; Duband-Goulet I; Zinn-Justin S; Kamps M; Kuijpers HJ; Ostlund C; Worman HJ; Briedé JJ; Le Dour C; Marcelis CL; van Geel M; Steijlen PM; van den Wijngaard A; Ramaekers FC; Broers JL
    J Cell Mol Med; 2009 May; 13(5):959-71. PubMed ID: 19220582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Lamin A Mutant Responsible for Congenital Muscular Dystrophy Causes Distinct Abnormalities of the Cell Nucleus.
    Barateau A; Vadrot N; Vicart P; Ferreiro A; Mayer M; Héron D; Vigouroux C; Buendia B
    PLoS One; 2017; 12(1):e0169189. PubMed ID: 28125586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B.
    Rønningen T; Shah A; Oldenburg AR; Vekterud K; Delbarre E; Moskaug JØ; Collas P
    Genome Res; 2015 Dec; 25(12):1825-35. PubMed ID: 26359231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2.
    Corsa CAS; Walsh CM; Bagchi DP; Foss Freitas MC; Li Z; Hardij J; Granger K; Mori H; Schill RL; Lewis KT; Maung JN; Azaria RD; Rothberg AE; Oral EA; MacDougald OA
    Diabetes; 2021 Sep; 70(9):1970-1984. PubMed ID: 34088712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix remodeling and transforming growth factor-β signaling abnormalities induced by lamin A/C variants that cause lipodystrophy.
    Le Dour C; Wu W; Béréziat V; Capeau J; Vigouroux C; Worman HJ
    J Lipid Res; 2017 Jan; 58(1):151-163. PubMed ID: 27845687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new laminopathy caused by an Arg133/Leu mutation in
    Wang Z; Dong Y; Yang J; He Y; Lin X; Wu F; Li H; Zheng F
    Adipocyte; 2019 Dec; 8(1):280-291. PubMed ID: 31293201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.